1
|
Zhong WD, Zhang YQ, Hu G, Zhao ZG, Li W, Liu JC, Dai LL, Wang SR, Zhou YH, Shao GY. [Application of endoluminal vacuum-assisted closure device in the treatment of gastrointestinal fistula]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:874-877. [PMID: 37709697 DOI: 10.3760/cma.j.cn441530-20230608-00197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/16/2023]
|
2
|
Ma JW, Ren LL, Huang JC, Bao SZ, Dai LL, Ying J, Bian XY. [Efficacy of sacubitril/valsartan in peritoneal dialysis patients with HFpEF and its effect on residual renal function]. Zhonghua Yi Xue Za Zhi 2023; 103:117-124. [PMID: 36597739 DOI: 10.3760/cma.j.cn112137-20220922-01998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Objective: To investigate the efficacy of sacubitril/valsartan in peritoneal dialysis (PD) patients with heart failure with preserved ejection fraction (HFpEF) and its effect on residual renal function. Methods: PD patients with HFpEF in Ningbo First Hospital from March 2018 to August 2021 were retrospectively enrolled and divided into study group with sacubitril/valsartan and control group with valsartan. The clinical baseline data before treatment and clinical indicators during follow-up (6 and 12 months after treatment) were collected and compared between the two groups, and the adverse reactions were also recorded. Results: A total of 99 patients were included in the study. There were 61 patients in the study group, including 44 males and 17 females, with a mean age of (52±13) years. Meanwhile, there were 38 patients in the control group, including 23 males and 15 females, with a mean age of (57±14) years. There was no statistically significant difference in clinical baseline data between the two groups (e.g., age, sex, body mass index, duration of dialysis) (all P>0.05). The N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left ventricular end-systolic dimension (LVDs) were lower, but the left ventricular ejection fraction (LVEF) was higher in the study group than those in the control group at 6 and 12 months after treatment (all P<0.05). The systolic blood pressure (SBP) and diastolic blood pressure (DBP) of the two groups were lower than baseline values at 6 and 12 months after treatment respectively, with statistically significant differences (all P<0.05). However, there were no statistically significant differences in the decreases of SBP and DBP between the two groups at 6 and 12 months after treatment (all P>0.05). The decrease extents in residual estimated glomerular filtration rate (eGFR) [0.52 (-0.05, 1.19) vs 1.72 (0.97, 2.39) ml·min-1·(1.73 m2)-1, P<0.001]and 24-h residual urine volume [200 (-100, 300) vs 300 (137, 400) ml, P=0.018] at 12 months after treatment were lower in the study group than those in the control group. During the follow-up period, hyperkalemia occurred in 16 cases (26.2%) and 13 cases (34.2%) in the study group and the control group, and hypotension occurred in 3 cases (4.9%) and 1 case (2.6%) in the study group and the control group, respectively. There were no adverse reactions such as cough and angioneurotic edema in the two groups. Conclusions: Sacubitril/valsartan can safely and effectively improve cardiac function and lower blood pressure in PD patients with HFpEF. Compared with valsartan, sacubitril/valsartan may be more beneficial to delay the loss of residual renal function in PD patients with HFpEF.
Collapse
Affiliation(s)
- J W Ma
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| | - L L Ren
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| | - J C Huang
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| | - S Z Bao
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| | - L L Dai
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| | - J Ying
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| | - X Y Bian
- Department of Nephrology, Ningbo First Hospital (Ningbo Hospital of Zhejiang University), Ningbo 315000, China
| |
Collapse
|
3
|
Dai LL, Zhu YB, Bai RH, Li Q, Tao RY, Liu LC, Ding JB, Ma F, Zhao X, Cheng SK, Huang XL, Liu MS. Time resolved absolute extreme ultraviolet radiation measurement on the ENN XuanLong-50 spherical tokamak. Rev Sci Instrum 2021; 92:083507. [PMID: 34470401 DOI: 10.1063/5.0040648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2020] [Accepted: 07/26/2021] [Indexed: 06/13/2023]
Abstract
A plasma radiation measurement system for a wide spectral range, based on compact Absolute eXtreme UltraViolet (AXUV) silicon photodiodes, has been implemented on the newly constructed ENN XuanLong-50 (EXL-50) spherical tokamak. The system consists of two 16-channel AXUV16ELG arrays and one AXUV63HS1 single-cell detector mounted on ceramic sockets. The two arrays, facing toward the EXL-50 slim central post from two locations inside a top and a side ConFlat 400 port, have 32 view chords covering the interested plasma region in a poloidal cross section at toroidal 330°. The single-cell detector, seated on a retractable feedthrough, could be arranged flexibly with the help of an ultra-high vacuum compatible gate valve. The design details together with considerations on the EXL-50 specific engineering realities and physics requirements are described. Preliminary results from the EXL-50 2020 experimental campaign are presented.
Collapse
Affiliation(s)
- L L Dai
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - Y B Zhu
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - R H Bai
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - Q Li
- Department of Modern Physics, University of Science and Technology of China, Hefei 230026, China
| | - R Y Tao
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - L C Liu
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - J B Ding
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - F Ma
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - X Zhao
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - S K Cheng
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - X L Huang
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - M S Liu
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| |
Collapse
|
4
|
Huang XL, Zhang YP, Zhu YB, Li X, He L, Li YX, Zhou J, Cheng SK, Yang YM, Bai RH, Zhao X, Tao RY, Chen B, Dai LL, Zeng GQ, Liu Y, Liu MS. Toroidal soft x-ray array on the EXL-50 spherical tokamak. Rev Sci Instrum 2021; 92:053501. [PMID: 34243359 DOI: 10.1063/5.0040511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Accepted: 04/12/2021] [Indexed: 06/13/2023]
Abstract
A toroidal soft x-ray array system for spectrum and intensity measurements on the EXL-50 spherical tokamak is described. Silicon drift detectors and digital multichannel analyzers are adopted for all 21 channels of the array, and an average energy resolution of 147 eV at 5.89 keV has been achieved at count rates over 500 kcps. In total, 20 channels of the array are symmetrically observed in both co- and counter-current directions on the EXL-50 mid-plane with a spatial resolution of around 10 cm, and the remaining one serves as a background reference channel. Tungsten emissions from tungsten coating of the limiters on the central post are observed. The influence of hard x rays on measured soft x-ray spectra and system operation is discussed.
Collapse
Affiliation(s)
- X L Huang
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - Y P Zhang
- Southwestern Institute of Physics, P.O. Box 432, Chengdu 610041, China
| | - Y B Zhu
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - X Li
- Southwestern Institute of Physics, P.O. Box 432, Chengdu 610041, China
| | - L He
- Chengdu University of Technology, Chengdu 610059, China
| | - Y X Li
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - J Zhou
- Southwestern Institute of Physics, P.O. Box 432, Chengdu 610041, China
| | - S K Cheng
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - Y M Yang
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - R H Bai
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - X Zhao
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - R Y Tao
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - B Chen
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - L L Dai
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| | - G Q Zeng
- Chengdu University of Technology, Chengdu 610059, China
| | - Y Liu
- Southwestern Institute of Physics, P.O. Box 432, Chengdu 610041, China
| | - M S Liu
- Hebei Key Laboratory of Compact Fusion, Langfang 065001, China
| |
Collapse
|
5
|
Cheng SK, Zhu YB, Chen ZY, Li YX, Bai RH, Chen B, Huang XL, Dai LL, Liu MS. Tangential hard x-ray diagnostic array on the EXL-50 spherical tokamak. Rev Sci Instrum 2021; 92:043513. [PMID: 34243380 DOI: 10.1063/5.0040636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Accepted: 03/15/2021] [Indexed: 06/13/2023]
Abstract
A tangential hard x-ray (HXR) diagnostic on the newly constructed ENN XuanLong-50 (EXL-50) spherical tokamak for fast electron emission studies is presented. The HXR detection system consists of a symmetrical CdZnTe semiconductor detector array with a spectral sensitivity range of 20-300 keV. 25 channels have been designed on the 270° horizontal vacuum port with 12 sight lines to observe the forward emission, 12 sight lines to observe the backward emission of fast electrons, and 1 for viewing the central. Currently, ten channels have been in operation in the EXL-50 experiments. The systems are designed to measure the x-ray spectra for the estimation of fast electron temperature and electron velocity distribution in the EXL-50 experiment, which will be useful for understanding the dynamics of fast electrons generated by electron cyclotron resonance heating, for plasma instability and transport studies and for the analysis of plasma heating efficiency.
Collapse
Affiliation(s)
- S K Cheng
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - Y B Zhu
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - Z Y Chen
- International Joint Research Laboratory of Magnetic Confinement Fusion and Plasma Physics, State Key Laboratory of Advanced Electromagnetic Engineering and Technology, School of Electrical and Electronic Engineering, Huazhong University of Science and Technology, Wuhan 430074, China
| | - Y X Li
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - R H Bai
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - B Chen
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - X L Huang
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - L L Dai
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| | - M S Liu
- Hebei Key Laboratory of Compact Fusion, Langfang, Hebei, 065001, China
| |
Collapse
|
6
|
Jiang TY, Hou JH, Su B, Zhang T, Yang Y, Liu ZY, Wang W, Guo CP, Dai LL, Sun LJ, Wu H. Demographic and clinical factors associated with immune reconstitution in HIV/HBV co-infected and HIV mono-infected patients: a retrospective cohort study. HIV Med 2020; 21:722-728. [PMID: 33369028 DOI: 10.1111/hiv.13023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/13/2020] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To describe the clinical characteristics and factors associated with CD4 T-cell count and CD4/CD8 ratio restoration in HIV mono-infected and HIV/HBV co-infected individuals, and to explore liver and renal functional changes in both groups. METHODS A retrospective cohort study was performed including 356 HIV/HBV co-infected and 716 HIV mono-infected participants who initiated antiretroviral therapy (ART) during 2013-2017 in Beijing Youan Hospital, China. Demographic and clinical characteristics were compared between the two groups, using χ2 and Mann-Whitney non-parametric tests. Bivariate and multivariate Cox regression models were used to test their association. RESULTS Baseline HIV viral load and ART regimen were found to be significantly associated with CD4 T-cell restoration among HIV-infected participants, whereas baseline HIV viral load was the only significant factor associated with CD4 T-cell restoration in HIV/HBV co-infected participants. The final model showed that baseline HIV viral load and ART regimen were significantly associated with CD4/CD8 ratio restoration among HIV-infected participants, while baseline HIV viral load was the significant factor. Liver and renal functions were similar at the endpoint (P > 0.05). CONCLUSIONS Baseline HIV viral load count was found to be the key factor affecting immune restoration in both HIV and HIV/HBV individuals. Future multi-wave prospective studies are needed to clarify the potential biological mechanism.
Collapse
Affiliation(s)
- T Y Jiang
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory for HIV/AIDS Research, Beijing, China
| | - J H Hou
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory for HIV/AIDS Research, Beijing, China
| | - B Su
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory for HIV/AIDS Research, Beijing, China
| | - T Zhang
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory for HIV/AIDS Research, Beijing, China
| | - Y Yang
- Network Center, Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - Z Y Liu
- Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - W Wang
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - C P Guo
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - L L Dai
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory for HIV/AIDS Research, Beijing, China
| | - L J Sun
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - H Wu
- Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China
| |
Collapse
|
7
|
Cheng Z, Yang YJ, Jing XG, Dai LL, Wang X, Jia LQ, Wang H, Jiang TC, An L, Liu M, Yang M, Li WF, Li Y. [Diagnostic value of HBP, PCT combined with APACHE Ⅱ score respectively in ventilator-associated pneumonia]. Zhonghua Yi Xue Za Zhi 2019; 99:1698-1702. [PMID: 31216814 DOI: 10.3760/cma.j.issn.0376-2491.2019.22.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the diagnostic value of the heparin-binding protein (HBP), procalcitonin (PCT) and acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score in ventilator-associated pneμmonia (VAP). Methods: A total of 160 patients who required tracheotomy or intubation and assisted breathing with invasive mechanical ventilator from the First Affiliated Hospital of Zhengzhou University from January 2015 to January 2017 was included in this prospective study,and divided into VAP group and no-VAP group based on if VAP happened or not; the VAP group was further divided into deterioration group and improvement group based on the curative effect after anti-infective treatment for 1 week. A total of 40 community acquired pneumonia (CAP) patients and 30 healthy volunteers were also included as control groups. The levels of HBP and PCT in blood of the subjects were tested with enzyme-linked immuno sorbent assay (ELISA) and chemiluminescence immunoassay (ECLIA) respectively, APACHE Ⅱ score was utilized to assess the severity of illness. The difference of HBP, PCT levels and APACHE Ⅱ score among the groups were analyzed. Receiver operating characteristic(ROC) curve was utilized to analyze the diagnostic value of HBP, PCT, APACHE Ⅱ score in VAP. Results: A total of 230 subjects participated in this study, including 68 VAP patients, 92 non-VAP patients, 40 CAP patients and 30 healthy volunteers. Before administration of mechanical ventilation, there were no statistically significant differences in HBP, PCT and APACHE Ⅱ score between VAP group and non-VAP group (all P>0.05). The levels of HBP,PCT and APACHE Ⅱ score were (41.4±21.3) μg/L,(0.355±0.254) μg/L,(13.4±2.5) respectively when the VAP was diagnosed,which were higher than those within the first 12 h of mechanical ventilation (7.3±2.7) μg/L, (0.080±0.038) μg/L, (8.4±2.0), all P<0.001). The HBP, PCT and APACHE Ⅱ score had no significant difference between within the first 12 h of mechanical ventilation and after mechanical ventilation in non-VAP group (all P>0.05). The levels of HBP was positively correlated with PCT and APACHE Ⅱ score (r=0.82, 0.68, all P<0.001). In deterioration group,the HBP,PCT and APACHE Ⅱ score after 1 week of anti-infective treatment were higher than those when the VAP was diagnosed (all P<0.001). No matter it is when the VAP was diagnosed or after anti-infective treatment for 1 week,the levels of HBP, PCT and APACHE Ⅱ score in deterioration group were higher than those in the improvement group (all P<0.001). The area under curve (AUC) of HBP+APACHE Ⅱ score, PCT+APACHE Ⅱ score for VAP diagnosis was 0.98, 0.95 respectively. The sensitivity of HBP+APACHE Ⅱ score in the diagnosis of VAP was lower than PCT+APACHE Ⅱ score (94.1% vs 95.6%),and the specificity was higher (92.4% vs 82.6%). Conclusion: The diagnostic value of HBP+APACHE Ⅱ score for early VAP is superior to PCT+APACHE Ⅱ score.
Collapse
Affiliation(s)
- Z Cheng
- The First Affiliated Hospital of Zhengzhou University, Pulmonary and Critical Care Medicine, Zhengzhou 450052, China
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Li Y, Zhou XH, Chen ZH, Dai LL, Cui CX, Wu HL, Wei QY, Fan KM, Xu YL. [Carcinogenicity study of CD133(+)CD44(+) laryngeal cancer stem cells and identification of related microRNAs]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019; 54:529-533. [PMID: 31315361 DOI: 10.3760/cma.j.issn.1673-0860.2019.07.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the carcinogenic abilities of CD133(+)CD44(+) laryngeal cancer stem cells and general laryngeal cancer stem cells and to identify the mechanism underlying the action of miRNAs. Methods: Solid tumor-derived laryngeal carcinoma stem cells and Hep-2-derived laryngeal carcinoma stem cells were cultured, and CD133(+)CD44(+) laryngeal cancer stem cells were sorted by flow cytometry. Boden chamber invasion assay, cell migration assay and tumor formation assay were then performed to compare the invasion, migration and tumorigenic abilities of CD133(+)CD44(+) laryngeal cancer stem cells and general laryngeal cancer stem cells. And then, miRNAs isolated from two laryngeal cancer stem cells were detected and analysed with miRNA chip. Results: (1)In Boyden chamber invasion assay, the cell invasion rate of CD133(+)CD44(+) laryngeal cancer stem cells was obviously higher (80.2%±2.3% vs. 63.9%±3.2%, t=5.011, P=0.027); (2)CD133(+)CD44(+) laryngeal cancer stem cells also had higher mobility in cell migration assay (82.9%±1.1% vs. 70.9%±0.6%, t=4.514, P=0.031); (3)In tumor formation assay, the tumor formation rate of CD133(+)CD44(+) laryngeal cancer stem cells was also higher (80% vs. 50%). What's more, we identified 15 miRNAs that were significantly upregulated in CD133(+)CD44(+) laryngeal cancer stem cells and 3 miRNAs that were significantly downregulated in CD133(+)CD44(+) laryngeal cancer stem cells, compared with normal laryngeal cancer stem cells. Conclusions: CD133(+)CD44(+) laryngeal cancer stem cells have stronger invasion, migration and tumorigenic abilities compared with normal laryngeal cancer stem cells, and the difference of miRNAs' expression is one of the possible causes.
Collapse
Affiliation(s)
- Y Li
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - X H Zhou
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - Z H Chen
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - L L Dai
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - C X Cui
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - H L Wu
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - Q Y Wei
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - K M Fan
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| | - Y L Xu
- Department of Otorhinolaryngology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
| |
Collapse
|
9
|
Cheng Z, Dai LL, Liu Q, Liu M, Wang Q, Li PF, Wang H, Jia LQ, An L. Correlation between polymorphisms in the glucocorticoid receptor gene NR3C1 and susceptibility to asthma in a Chinese population from the Henan Province. Genet Mol Res 2016; 15:gmr8507. [PMID: 27323143 DOI: 10.4238/gmr.15028507] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The aim of this study was to investigate the association between four single nucleotide polymorphisms in NR3C1 (Tth111I, BclI, ER22/23EK, and N363S), which encode the glucocorticoid receptor, and asthma susceptibility in patients from the Henan Province of China. Three hundred and twenty-eight patients with asthma and 60 healthy volunteers were recruited to this study. The target SNPs were genotyped by polymerase chain reaction (PCR)-high resolution melting and PCR-restriction fragment length polymorphism. The frequencies of the AA (8.84%) and GG (30.79%) genotypes of Tth111I were higher, and that of the AG genotype was lower (60.37%), in the asthma patients compared to that seen in healthy controls (5.00, 26.67, and 68.33%, respectively). On the other hand, asthma patients showed higher frequencies of the AA genotype (78.05%) of N363S, and lower frequencies of the AG and GG genotypes (15.55 and 6.40%), compared to healthy volunteers (71.67, 18.33, and 10.00%, respectively). Neither of these differences were found to be statistically significant. Moreover, we observed no significant differences in the genotype or allele frequencies of the BclI and ER22/23EK SNPs between the patient and control groups. In conclusion, SNPs in NR3C1 were not significantly associated with asthma in patients from the Henan Province. Patients showed higher frequencies of the AA and GG genotypes of Tth111I and the AA genotype of the N363S SNP compared to healthy volunteers, although these differences were not significant.
Collapse
Affiliation(s)
- Z Cheng
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L L Dai
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Q Liu
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - M Liu
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Q Wang
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - P F Li
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - H Wang
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L Q Jia
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - L An
- Respiratory and Critical Care Medicine, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.,Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
10
|
Abstract
OBJECTIVE To explore the effects of phthalanilic acid on immune system in mice from the respects of blood, tissues, cell and cytokines. And to find sensitive index of immunological effects and offer experimental data for toxicological safety evaluation. METHODS 60 balb/c mice were randomly divided into 4 groups. The mice in control group were given soybean oil. The mice in group 2 to 4 were given phthalanilic acid at dose 30 mg/kg, 100 mg/kg and 300 mg/kg by gavage respectively for 28 days. After 24 hours of the last contamination, the histopathology of spleen and thymus, immunologic factors and cell multiplication of lymphocyte were analysed. The data were analysed by SPSS. RESULTS After contamination for 28 days, 300 mg/kg phthalanilic acid could cause that the cell multiplication of lymphocyte were inhibited. Spleens were damaged at the dose of 100 mg/kg. The concentration of IFN-γ and IL-4[ (843.31±14.81) pg/ml and (1174.44±7.32) pg/ml] in thymus were increased significantly (P<0.05) at the dose of 30 mg/kg. CONCLUSION Different doses of phthalanilic acid may damnify the immune system of mice at different degrees for 28 days continuous contamination. Phthalanilic acid might have immunotoxicity.
Collapse
Affiliation(s)
- L L Dai
- Department of Toxicology, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | | | | | | |
Collapse
|
11
|
Cheng Z, Dai LL, Song YN, Kang Y, Si JM, Xia J, Liu YF. Regulatory effect of iron regulatory protein-2 on iron metabolism in lung cancer. Genet Mol Res 2014; 13:5514-22. [PMID: 25117307 DOI: 10.4238/2014.july.25.5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Iron metabolism plays an important role in the pathogenesis of lung cancer. This study aimed to investigate the effect of gene silencing of iron regulatory protein-2 (IRP2) on mRNA and protein expression of transferrin (Tf), transferrin receptor (TfR), and ferritin (Fn) in A549 lung cancer cells. A549 cells were cultured and divided into a liposome control group, a liposome + oligonucleotide (SCODN) control group, and a Lipofectamine + antisense oligonucleotide (ASODN) group. RT-PCR and Western blotting were used to detect mRNA and protein expression of Tf, TfR, and Fn. We found no significant change in Tf mRNA expression among the 3 groups (P = 0.078). TfR and Fn mRNA expressions in the ASODN group notably decreased compared to the liposome and SCODN groups (P < 0.01). IRP2 and TfR protein expressions in the ASODN group were significantly lower than in the liposome or SCODN groups (P < 0.05), whereas no significant change in Tf protein expression was observed between the 3 groups (P = 0.088). Fn protein expression in the ASODN group was significantly higher than in the liposome or SCODN group (P < 0.05). IRP2 can regulate the expression of TfR and Fn by changing its own protein expression and thereby regulate iron metabolism.
Collapse
Affiliation(s)
- Z Cheng
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| | - L L Dai
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| | - Y N Song
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| | - Y Kang
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| | - J M Si
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| | - J Xia
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| | - Y F Liu
- Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Institute of Clinical Medicine, Zhengzhou, China
| |
Collapse
|
12
|
Wang HJ, Tang ZL, Lin ZM, Dai LL, Chen Q, Yang Y. Recurrent splice-site mutation in MBTPS2underlying IFAP syndrome with Olmsted syndrome-like features in a Chinese patient. Clin Exp Dermatol 2013; 39:158-61. [PMID: 24313295 DOI: 10.1111/ced.12248] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/16/2013] [Indexed: 12/01/2022]
Affiliation(s)
- H. J. Wang
- Department of Dermatology; Peking University First Hospital; Beijing China
- Peking-Tsinghua Center for Life Sciences; Beijing China
| | - Z. L. Tang
- Department of Dermatology; The Affiliated Hospital of Qingdao University Medical College; Qingdao China
| | - Z. M. Lin
- Department of Dermatology; Peking University First Hospital; Beijing China
| | | | - Q. Chen
- Department of Dermatology; Peking University First Hospital; Beijing China
| | - Y. Yang
- Department of Dermatology; Peking University First Hospital; Beijing China
- Peking-Tsinghua Center for Life Sciences; Beijing China
| |
Collapse
|